Zeiss under the agreement with Optiscan are able to use the the product for ENT applications (mentioned in paper) so without trying to get too excited, when the Neuro product is launched and is successful the step to other cancers will be a short one.
Optics.org:diagnostic capability of endoscopy, page-6
Add OIL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
22.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $183.7M | |||
| Open | High | Low | Value | Volume |
| 22.0¢ | 22.0¢ | 21.5¢ | $14.70K | 67.42K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 59068 | 21.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 22.5¢ | 15000 | 1 |
View Market Depth
| Last trade - 15.33pm 24/07/2024 (20 minute delay) ? |
| OIL (ASX) Chart |